Symptom trajectories in patients with panic disorder in a primary care intervention: Results from a randomized controlled trial (PARADISE).
Karoline LukaschekThomas S HillerUlrike SchumacherTobias TeismannJörg BreitbartChristian BrettschneiderHans-Helmut KönigJürgen MargrafJochen GensichenPublished in: Scientific reports (2019)
This analysis aims to identify and characterize symptom trajectories in primary care patients with panic disorder with/without agoraphobia (PD/AG) who participated in a primary care team based training involving elements of cognitive behavioural therapy (CBT). Growth Mixture Modeling was used to identify different latent classes of change in patients with PD/AG (N = 176) who underwent treatment including CBT elements. We identified three patient classes with distinct similar trajectories. Class 1 (n = 58, mean age: 46.2 years ± 13.4 years, 81% women) consisted of patients with an initially high symptom burden, but symptoms declined constantly over the intervention period. Symptoms of patients in class 2 (n = 89, mean age: 44.2 years ± 14.5 years, 67.4% women) declined rapidly at the beginning, then patients went into a plateau-phase. The third class (n = 29, mean age: 47.0 years ± 12.4 years, 65.5% women) was characterized by an unstable course and had the worse outcome. Our findings show that only a minority did not respond to the treatment. To identify this minority and refer to a specialist would help patients to get intensive care in time.
Keyphrases
- primary care
- end stage renal disease
- chronic kidney disease
- randomized controlled trial
- palliative care
- depressive symptoms
- polycystic ovary syndrome
- prognostic factors
- peritoneal dialysis
- patient reported
- type diabetes
- patient reported outcomes
- stem cells
- insulin resistance
- mesenchymal stem cells
- adipose tissue
- skeletal muscle
- bone marrow
- replacement therapy
- cervical cancer screening